These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16641138)

  • 1. Protective effect of fasudil, a Rho-kinase inhibitor, on chemokine expression, leukocyte recruitment, and hepatocellular apoptosis in septic liver injury.
    Thorlacius K; Slotta JE; Laschke MW; Wang Y; Menger MD; Jeppsson B; Thorlacius H
    J Leukoc Biol; 2006 May; 79(5):923-31. PubMed ID: 16641138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasudil, a Rho-kinase inhibitor, inhibits leukocyte adhesion in inflamed large blood vessels in vivo.
    Slotta JE; Braun OO; Menger MD; Thorlacius H
    Inflamm Res; 2006 Sep; 55(9):364-7. PubMed ID: 17122957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p38 mitogen-activated protein kinase-dependent chemokine production, leukocyte recruitment, and hepatocellular apoptosis in endotoxemic liver injury.
    Klintman D; Li X; Santen S; Schramm R; Jeppsson B; Thorlacius H
    Ann Surg; 2005 Dec; 242(6):830-8, discussion 838-9. PubMed ID: 16327493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of CXC chemokines in endotoxemic liver injury in mice.
    Li X; Klintman D; Liu Q; Sato T; Jeppsson B; Thorlacius H
    J Leukoc Biol; 2004 Mar; 75(3):443-52. PubMed ID: 14673016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment with Rho-kinase inhibitor ameliorates lethal endotoxemia-induced liver injury by improving mitochondrial function.
    Ding R; Han J; Zhao D; Hu Z; Ma X
    Int Immunopharmacol; 2016 Nov; 40():125-130. PubMed ID: 27588912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
    Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
    Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rho-kinase signalling mediates endotoxin hypersensitivity after partial hepatectomy.
    Slotta JE; Laschke MW; Menger MD; Thorlacius H
    Br J Surg; 2008 Aug; 95(8):976-84. PubMed ID: 18563790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Rho-kinase inactivation on eosinophilia and hyper-reactivity in murine airways by allergen challenges.
    Taki F; Kume H; Kobayashi T; Ohta H; Aratake H; Shimokata K
    Clin Exp Allergy; 2007 Apr; 37(4):599-607. PubMed ID: 17430358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pretreatment of Rho kinase inhibitor inhibits systemic inflammation and prevents endotoxin-induced acute lung injury in mice.
    Ding RY; Zhao DM; Zhang ZD; Guo RX; Ma XC
    J Surg Res; 2011 Dec; 171(2):e209-14. PubMed ID: 21962807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rho-kinase inhibitor attenuates cholestasis-induced CXC chemokine formation, leukocyte recruitment, and hepatocellular damage in the liver.
    Laschke MW; Dold S; Jeppsson B; Schilling MK; Menger MD; Thorlacius H
    J Surg Res; 2010 Apr; 159(2):666-73. PubMed ID: 19159908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Important role of P-selectin for leukocyte recruitment, hepatocellular injury, and apoptosis in endotoxemic mice.
    Klintman D; Li X; Thorlacius H
    Clin Diagn Lab Immunol; 2004 Jan; 11(1):56-62. PubMed ID: 14715545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allopurinol inhibits CXC chemokine expression and leukocyte adhesion in endotoxemic liver injury.
    Xiang L; Klintman D; Thorlacius H
    Inflamm Res; 2003 Sep; 52(9):353-8. PubMed ID: 14504661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasudil inhibits neutrophil-endothelial cell interactions by regulating the expressions of GRP78 and BMPR2.
    Wang J; Xu J; Zhao X; Xie W; Wang H; Kong H
    Exp Cell Res; 2018 Apr; 365(1):97-105. PubMed ID: 29481792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling Rho-kinase mediates inflammation and apoptosis in T cells and renal tubules in cisplatin nephrotoxicity.
    Nozaki Y; Kinoshita K; Hino S; Yano T; Niki K; Hirooka Y; Kishimoto K; Funauchi M; Matsumura I
    Am J Physiol Renal Physiol; 2015 Apr; 308(8):F899-909. PubMed ID: 25651561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The selective Rho-kinase inhibitor Fasudil is protective and therapeutic in experimental autoimmune encephalomyelitis.
    Sun X; Minohara M; Kikuchi H; Ishizu T; Tanaka M; Piao H; Osoegawa M; Ohyagi Y; Shimokawa H; Kira J
    J Neuroimmunol; 2006 Nov; 180(1-2):126-34. PubMed ID: 16996142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasudil, a Rho-kinase inhibitor, attenuates lipopolysaccharide-induced vascular hyperpermeability and colonic muscle relaxation in guinea pigs.
    Suzuki K; Nemoto K; Ninomiya N; Kuno M; Kubota M; Yokota H
    J Surg Res; 2012 Nov; 178(1):352-7. PubMed ID: 22487385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
    Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
    Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central role of rho kinase in lipopolysaccharide-induced platelet capture on venous endothelium.
    Slotta JE; Braun OO; Menger MD; Thorlacius H
    J Investig Med; 2008 Apr; 56(4):720-5. PubMed ID: 18382268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rho-kinase signalling regulates CXC chemokine formation and leukocyte recruitment in colonic ischemia-reperfusion.
    Santen S; Wang Y; Laschke MW; Menger MD; Jeppsson B; Thorlacius H
    Int J Colorectal Dis; 2010 Sep; 25(9):1063-70. PubMed ID: 20593289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Rho-kinase in tumor necrosis factor-alpha-induced interleukin-6 release from C6 glioma cells.
    Yamaguchi S; Tanabe K; Takai S; Matsushima-Nishiwaki R; Adachi S; Iida H; Kozawa O; Dohi S
    Neurochem Int; 2009 Nov; 55(6):438-45. PubMed ID: 19427347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.